Satellite Symposia
Wednesday, 19 October 2011
12.30 – 14.00
Bowel and Brain
European Charcot Foundation
17.15 – 18.15
Managing MS in changing treatment landscape
Teva
18.30 – 19.30
Oral therapy (r)evolution in MS: Clinical experience and impact on patient outcomes
Sanofi
Thursday, 20 October 2011
12.45 – 13.45
Addressing MS patient needs today and tomorrow
Biogen Idec
18.00 – 19.00
MS: It’s a marathon, not a sprint. Optimizing patient outcomes throughout the MS journey
Merck Serono S.A.
19.15 – 20.15
Early treatment and beyond: making meaningful connections
Bayer HealthCare Pharmaceuticals
Friday, 21 October 2011
08.00 – 09.00
Multimodal management in multiple sclerosis – Improving Quality of Life
Allergan
12.45 – 13.45
Fingolimod symposium
Novartis Pharma AG
18.00 – 19.00
Advances in the management of MS-related spasticity
Almirall
19.15 – 20.15
Evolving treatment expectations in MS: Where are we going?
Genzyme